Publications by authors named "B Balaban Kocas"
Objectives: Although the association of Atherogenic index of plasma (AIP) with coronary artery disease (CAD) and atherosclerosis is known, the relationship between AIP and in-stent restenosis (ISR) remains unclear. We aimed to investigate the relationship between AIP and ISR in patients with stable angina pectoris (SAP) treated with drug-eluting stent (DES).
Methods: Patients with a history of DES implantation following stable angina were evaluated between January 2015 and November 2019 in this observational and retrospective study.
Article Synopsis
- The study explores the effectiveness of SYNTAX Score II (SS-II) in predicting mortality for patients with ST-segment elevation myocardial infarction (STEMI) who underwent primary percutaneous coronary intervention (p-PCI).
- Researchers analyzed data from 743 STEMI patients, grouping them into low, mid, and high SS-II categories to examine in-hospital and long-term mortality rates.
- Findings revealed that patients in the high SS-II group had significantly higher rates of in-hospital (15%) and all-cause mortality (32.2%), establishing SS-II >31 as a strong independent predictor of mortality risk.
Since December 2019, the novel coronavirus (COVID-19) outbreak has become an important public health problem and one of the most common causes of morbidity and mortality worldwide. COVID-19 is highly associated with thromboembolic events, like deep venous thrombosis and pulmonary embolism (PE). Catheter-directed thrombolysis (CDT) provides effective reperfusion for the treatment of PE.
View Article and Find Full Text PDFTo investigate the relationship between post-myocardial infarction (MI) left ventricular ejection fraction (LVEF) and fibrosis marker HE-4 in primarily revascularized patients with ST-segment elevation MI (STEMI). In 94 consecutive STEMI patients (median age 57 [IQR: 50-69] years; 77.7% male), HE-4 values were measured at hospital admission and 4 days after STEMI.
View Article and Find Full Text PDFArticle Synopsis
- The study evaluates the Modified Anticoagulation and Risk Factors in Atrial Fibrillation Risk Score (M-ATRIA-RS) to determine its effectiveness in predicting in-hospital mortality for COVID-19 patients, comparing it to other scoring systems like CHADS and CHA2DS2-VASc.
- Data from 1,001 patients was analyzed, revealing that higher M-ATRIA-RS scores correlated significantly with increased mortality rates and other severe clinical outcomes.
- The findings indicate that M-ATRIA-RS is an independent predictor of mortality, outperforming other scoring systems, and is easier to use than the Charlson Comorbidity Index (CCI).